RaySearch awarded treatment planning installation at premier cancer center in the US

MD Anderson Cancer Center recently closed a request for proposal (RFP) for the
acquisition of new radiation therapy planning software to expand current
approaches and investigate new technologies.
On August 18, 2015, a purchase agreement was signed, finalizing an RFP put
forward by The University of Texas MD Anderson Cancer Center, this spring, to
assist in the selection and assessment of new treatment planning technologies.

The conclusion and rationale for the selection of the RaySearch Laboratories
treatment planning system (TPS) was that “the RayStation® system offers a new
environment for radiotherapy treatment planning – optimizing leading-edge
hardware functionality to improve speed in TPS optimization and offer a ‘modern’
working environment. This system also offers alternative approaches to IMRT
optimization using a unique technology known as multi-criteria optimization
(MCO). Several other options exist in this system, such as adaptive and fallback
planning, some redundant with existing systems at MDACC, but the alternative
software will be explored,” stated the MD Anderson Cancer Center in the RFP
statement of work. The center will implement approximately thirty licenses
throughout the department, twenty for clinical use and ten for research, to
fully investigate which technologies have the biggest impact on its practice.

“Getting RayStation® into MD Anderson and working with the team there is a great
opportunity – we look forward to developing a research relationship that can
lead to novel and exciting functionality,” says Marc Mlyn, President of
RaySearch Americas, Inc. “We are pleased to have the opportunity to show how
RayStation® can positively impact the center’s workflow and help it achieve its
patient care goals,” he concludes.

“We are very pleased that such a highly respected institution as MD Anderson has
selected RayStation® in direct competition with all major TPS providers. This
provides strong confirmation of RayStation®’s many and unique advantages and
will demonstrate the impact it can have in a large clinical setting,” says Johan
Löf, CEO of RaySearch Laboratories AB.
About RayStation®

RayStation® integrates all RaySearch’s advanced treatment planning solutions
into a flexible treatment planning system. It combines unique features such as
multi-criteria optimization tools with full support for 4D adaptive radiation
therapy. It also includes functionality such as RaySearch’s market-leading
algorithms for IMRT and VMAT optimization and highly accurate dose engines for
photon, electron and proton therapy. The system is built on the latest software
architecture and has a graphical user interface offering state-of-the-art
usability.

About RaySearch

RaySearch Laboratories is a medical technology company that develops advanced
software solutions for improved radiation therapy of cancer. RaySearch markets
the RayStation® treatment planning system to clinics all over the world. In
addition, RaySearch’s products are distributed through licensing agreements with
leading medical technology companies. RaySearch’s software is used by over 2,500
clinics in more than 65 countries. RaySearch was founded in 2000 as a spin-off
from Karolinska Institutet in Stockholm and the company is listed in the Small
Cap segment on NASDAQ OMX Stockholm.

For more information about RaySearch, please visit www.raysearchlabs.com

For further information, please contact:

Johan Löf, President and CEO, RaySearch Laboratories AB

Telephone: 46 (0)8-510 530 00

johan.lof@raysearchlabs.com